Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Medtronic Inc (MDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 111,536,936
  • Shares Outstanding, K 1,354,590
  • Annual Sales, $ 29,710 M
  • Annual Income, $ 4,028 M
  • 36-Month Beta 1.00
  • Price/Sales 3.77
  • Price/Cash Flow 12.14
  • Price/Book 2.17

Price Performance

See More
Period Period Low Period High Performance
1-Month
77.06 +8.03%
on 11/03/17
84.11 -1.02%
on 11/21/17
+4.59 (+5.84%)
since 10/24/17
3-Month
76.51 +8.80%
on 10/09/17
84.11 -1.02%
on 11/21/17
+4.01 (+5.06%)
since 08/24/17
52-Week
69.35 +20.04%
on 01/03/17
89.72 -7.21%
on 06/26/17
+7.47 (+9.86%)
since 11/23/16

Most Recent Stories

More News
Will a 'Huge Tax Cut' Ease Burden for MedTech Players?

How is the MedTech industry placed in the wake of the current political conundrum surrounding tax reforms?

SNN : 35.78 (-0.03%)
ABMD : 199.74 (+0.44%)
JNJ : 138.00 (+0.52%)
MDT : 83.25 (+1.11%)
Global Insulin Pumps (External) Market, 2022 - Medtronic Banks on New Solutions and Distribution Expansion to Retain Dominance

The "Insulin Pumps (External) - Global Strategic Business Report" report has been added to Research and Markets' offering.

MDT : 83.25 (+1.11%)
Stock Market News For Nov 22, 2017

Benchmarks finished in the green on Tuesday following gains in the technology and healthcare sectors

GOOGL : 1,056.52 (+0.44%)
AAPL : 174.97 (+0.01%)
KIRK : 11.82 (-3.19%)
FB : 182.78 (+1.06%)
MDT : 83.25 (+1.11%)
PFE : 35.49 (+0.17%)
UNH : 212.51 (+0.61%)
GME : 17.42 (+0.29%)
Today's Research Reports on Stocks to Watch: Medtronic and Orasure Technologies

NEW YORK, NY / ACCESSWIRE / November 22, 2017 / Shares of Medtronic closed up nearly 5% after beating in both the top and bottom line in its second quarter earnings report. Shares of OraSure technologies...

OSUR : 16.38 (-2.85%)
MDT : 83.25 (+1.11%)
Asian stocks rise after Wall Street gain

BEIJING (AP) — Asian stocks rose Wednesday after Wall Street hit new highs ahead of the two-day U.S. break for the Thanksgiving holiday.

CPB : 46.04 (-1.56%)
GS : 235.95 (-0.20%)
MDT : 83.25 (+1.11%)
Medtronic, Hormel and Jacobs jump while Signet tumbles

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:

SIG : 49.77 (-6.11%)
CPB : 46.04 (-1.56%)
DSW : 20.59 (+1.28%)
JEC : 63.29 (-2.30%)
MDT : 83.25 (+1.11%)
HD : 172.33 (+0.16%)
MLNX : 58.30 (+2.10%)
Markets Right Now: US stock indexes reach more records

The latest on developments in financial markets (All times local):

MDT : 83.25 (+1.11%)
United States $6 Billion Insulin Delivery Devices Market Outlook to 2022 - Major Players are Insulet, Medtronic, Roche, Tandem Diabetes Care, Novo Nordisk, Eli Lilly, Sanofi & Owen Mumford

DUBLIN, November 21, 2017 /PRNewswire/ --

LLY : 84.03 (+0.42%)
MDT : 83.25 (+1.11%)
Medtronic (MDT) Beats on Q2 Earnings, Reiterates FY18 View

Medtronic (MDT) rides high on strength in major business segments in Q2.

PETS : 38.68 (-3.37%)
LMNX : 21.90 (+0.97%)
IDXX : 154.81 (+0.49%)
MDT : 83.25 (+1.11%)
Medtronic Wins FDA Nod for Azure Pacemakers, Grows in CVG

Medtronic (MDT) strives to improve its Cardiac Rhythm and Heart Failure division.

PETS : 38.68 (-3.37%)
MYGN : 33.26 (+1.19%)
MDT : 83.25 (+1.11%)
ALGN : 254.76 (+0.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

See More

Business Summary

Medtronic is the world's leading medical technology company, pioneeringdevice-based therapies that restore health, extend life and alleviate pain.Primary products include those for bradycardia pacing, tachyarrhythmiamanagement, atrial fibrillation management, among others. Medtronic operates its business...

See More

Key Turning Points

2nd Resistance Point 84.01
1st Resistance Point 83.63
Last Price 83.25
1st Support Level 82.74
2nd Support Level 82.23

See More

52-Week High 89.72
Last Price 83.25
Fibonacci 61.8% 81.94
Fibonacci 50% 79.54
Fibonacci 38.2% 77.13
52-Week Low 69.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart